Skip to content
10-Q

Quarterly Report

Coya Therapeutics, Inc. COYA

0001193125-25-276058

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 20.92M sh
Shares Diluted Q3 2025 · Sep 30, 2025 16.73M sh
Shares Diluted Q3 2025 · Sep 30, 2025 16.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 15.22M sh
Shares Diluted Q3 2025 · Sep 30, 2024 14.87M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$9.73M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$7.88M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $28.13M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $38.34M
Stockholders Equity Q3 2025 · Sep 30, 2025 $27.28M
Stockholders Equity Q3 2025 · Jun 30, 2025 $28.31M
Stockholders Equity Q3 2025 · Mar 31, 2025 $33.37M
Stockholders Equity Q3 2025 · Dec 31, 2024 $39.58M
Stockholders Equity Q3 2025 · Sep 30, 2024 $32.01M
Stockholders Equity Q3 2025 · Jun 30, 2024 $35.26M
Stockholders Equity Q3 2025 · Mar 31, 2024 $32.39M
Stockholders Equity Q3 2025 · Dec 31, 2023 $35.64M
Current Liabilities Q3 2025 · Sep 30, 2025 $3.67M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.82M
Total Liabilities Q3 2025 · Sep 30, 2025 $4.76M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.77M
Current Assets Q3 2025 · Sep 30, 2025 $32.02M
Current Assets Q3 2025 · Dec 31, 2024 $44.31M
Total Assets Q3 2025 · Sep 30, 2025 $32.04M
Total Assets Q3 2025 · Dec 31, 2024 $44.35M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.93
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.80
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.93
Eps Basic Q3 2025 · Sep 30, 2024 −$0.26
Eps Basic Q3 2025 · Sep 30, 2024 −$0.80
Sga Expense Q3 2025 · Sep 30, 2025 $2.56M
Sga Expense Q3 2025 · Sep 30, 2025 $8.18M
Sga Expense Q3 2025 · Sep 30, 2024 $2.22M
Sga Expense Q3 2025 · Sep 30, 2024 $6.75M
Net Income Q3 2025 · Sep 30, 2025 −$2.12M
Net Income Q3 2025 · Sep 30, 2025 −$15.52M
Net Income Q3 2025 · Jun 30, 2025 −$6.09M
Net Income Q3 2025 · Mar 31, 2025 −$7.31M
Net Income Q3 2025 · Sep 30, 2024 −$4.02M
Net Income Q3 2025 · Sep 30, 2024 −$11.97M
Net Income Q3 2025 · Jun 30, 2024 −$2.89M
Net Income Q3 2025 · Mar 31, 2024 −$5.05M
Operating Income Q3 2025 · Sep 30, 2025 −$2.43M
Operating Income Q3 2025 · Sep 30, 2025 −$16.52M
Operating Income Q3 2025 · Sep 30, 2024 −$4.45M
Operating Income Q3 2025 · Sep 30, 2024 −$13.17M
Revenue Q3 2025 · Sep 30, 2025 $3.56M
Revenue Q3 2025 · Sep 30, 2025 $3.99M
Revenue Q3 2025 · Sep 30, 2024 $3.55M